DE60130270D1 - Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn - Google Patents
Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohnInfo
- Publication number
- DE60130270D1 DE60130270D1 DE60130270T DE60130270T DE60130270D1 DE 60130270 D1 DE60130270 D1 DE 60130270D1 DE 60130270 T DE60130270 T DE 60130270T DE 60130270 T DE60130270 T DE 60130270T DE 60130270 D1 DE60130270 D1 DE 60130270D1
- Authority
- DE
- Germany
- Prior art keywords
- preparing
- treatment
- pharmaceutical preparation
- aminosalicylic acid
- colitis ulcerosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/DK2001/000677 WO2003032952A1 (en) | 2001-10-15 | 2001-10-15 | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60130270D1 true DE60130270D1 (de) | 2007-10-11 |
DE60130270T2 DE60130270T2 (de) | 2008-05-29 |
Family
ID=8149447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60130270T Expired - Lifetime DE60130270T2 (de) | 2001-10-15 | 2001-10-15 | Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1441700B1 (de) |
JP (1) | JP4726414B2 (de) |
KR (1) | KR100859358B1 (de) |
CN (1) | CN100506234C (de) |
AT (1) | ATE371441T1 (de) |
CA (1) | CA2462905C (de) |
DE (1) | DE60130270T2 (de) |
DK (1) | DK1441700T3 (de) |
ES (1) | ES2288999T3 (de) |
HK (1) | HK1068282A1 (de) |
IL (2) | IL161193A0 (de) |
MX (1) | MXPA04003506A (de) |
NO (1) | NO335042B1 (de) |
PT (1) | PT1441700E (de) |
WO (1) | WO2003032952A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070059368A1 (en) * | 2005-05-31 | 2007-03-15 | Cherukuri S R | Modified release formulations of anti-irritability drugs |
EP1470819A1 (de) * | 2003-04-23 | 2004-10-27 | Ferring B.V. | Sachet mit hohem Anteil an Mesalazin |
JP2007523664A (ja) * | 2003-04-23 | 2007-08-23 | フェリング ベスローテン フェンノートシャップ | 医薬組成物用サシェ |
EP1547601A1 (de) * | 2003-12-23 | 2005-06-29 | Ferring B.V. | Beschichtungsverfahren |
MX2007002443A (es) * | 2004-09-01 | 2007-05-04 | Procter & Gamble | Composiciones que comprenden acido 5-amino-2-hidroxibenzoico y un azucar reductor. |
GB0909680D0 (en) | 2009-06-05 | 2009-07-22 | Euro Celtique Sa | Dosage form |
EP2340812A1 (de) * | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung |
CA2810283A1 (en) * | 2010-09-10 | 2012-03-15 | Pharmazell Gmbh | Process for producing crystalline 5-aminosalicylic acid |
WO2013134348A1 (en) * | 2012-03-07 | 2013-09-12 | Santarus, Inc. | Controlled-release solid dosage forms of mesalamine |
CN103622974B (zh) * | 2013-12-05 | 2016-04-20 | 武汉武药科技有限公司 | 一种含美沙拉嗪和n-乙酰半胱氨酸的复方栓剂及其制备方法 |
EP3154523B1 (de) * | 2014-06-16 | 2018-11-21 | Valpharma International S.P.A. | Formulierung zur oralen verabreichung mit mesalazin |
ITUA20162293A1 (it) | 2016-04-05 | 2017-10-05 | Sofar Spa | Processo per formulazioni solide di mesalazina |
JP2017189121A (ja) * | 2016-04-11 | 2017-10-19 | 国立大学法人旭川医科大学 | 抗TNFα抗体適応疾患の治療における抗TNFα抗体投与時反応の発症リスクを判定する方法、並びに該判定用オリゴヌクレオチドキット |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1981002671A1 (en) * | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
JPH0334928A (ja) * | 1989-06-29 | 1991-02-14 | Teikoku Seiyaku Kk | 潰瘍性大腸炎およびクローン病治療用経口投与製剤 |
PL186790B1 (pl) * | 1995-12-21 | 2004-02-27 | Ferring Farma Lab | Farmaceutyczna kompozycja doustna zawierająca 5-ASA i zastosowanie 5-ASA do jej wytwarzania |
IT1303753B1 (it) * | 1998-11-13 | 2001-02-23 | Ct Lab Farm Srl | Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici. |
IT1318625B1 (it) * | 2000-07-14 | 2003-08-27 | Roberto Valducci | Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente. |
-
2001
- 2001-10-15 MX MXPA04003506A patent/MXPA04003506A/es active IP Right Grant
- 2001-10-15 AT AT01978213T patent/ATE371441T1/de active
- 2001-10-15 WO PCT/DK2001/000677 patent/WO2003032952A1/en active IP Right Grant
- 2001-10-15 DK DK01978213T patent/DK1441700T3/da active
- 2001-10-15 DE DE60130270T patent/DE60130270T2/de not_active Expired - Lifetime
- 2001-10-15 CN CNB018237096A patent/CN100506234C/zh not_active Expired - Lifetime
- 2001-10-15 KR KR1020047005406A patent/KR100859358B1/ko active IP Right Grant
- 2001-10-15 JP JP2003535756A patent/JP4726414B2/ja not_active Expired - Lifetime
- 2001-10-15 PT PT01978213T patent/PT1441700E/pt unknown
- 2001-10-15 ES ES01978213T patent/ES2288999T3/es not_active Expired - Lifetime
- 2001-10-15 CA CA2462905A patent/CA2462905C/en not_active Expired - Lifetime
- 2001-10-15 IL IL16119301A patent/IL161193A0/xx unknown
- 2001-10-15 EP EP01978213A patent/EP1441700B1/de not_active Expired - Lifetime
-
2004
- 2004-03-31 IL IL161193A patent/IL161193A/en not_active IP Right Cessation
- 2004-05-14 NO NO20042011A patent/NO335042B1/no not_active IP Right Cessation
-
2005
- 2005-01-24 HK HK05100633A patent/HK1068282A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1441700E (pt) | 2007-10-29 |
EP1441700A1 (de) | 2004-08-04 |
NO335042B1 (no) | 2014-09-01 |
IL161193A0 (en) | 2004-08-31 |
CA2462905A1 (en) | 2003-04-24 |
NO20042011L (no) | 2004-06-30 |
HK1068282A1 (en) | 2005-04-29 |
JP4726414B2 (ja) | 2011-07-20 |
EP1441700B1 (de) | 2007-08-29 |
CA2462905C (en) | 2011-04-12 |
DK1441700T3 (da) | 2007-10-08 |
WO2003032952A1 (en) | 2003-04-24 |
KR100859358B1 (ko) | 2008-09-22 |
JP2005509619A (ja) | 2005-04-14 |
IL161193A (en) | 2010-05-31 |
CN100506234C (zh) | 2009-07-01 |
MXPA04003506A (es) | 2004-07-23 |
KR20040047906A (ko) | 2004-06-05 |
ATE371441T1 (de) | 2007-09-15 |
CN1558752A (zh) | 2004-12-29 |
DE60130270T2 (de) | 2008-05-29 |
ES2288999T3 (es) | 2008-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068282A1 (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for usein treatment of ulcerative colitis and crohn's di sease | |
ATE248599T1 (de) | Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen | |
DE122005000001I2 (de) | Zweiwertige Metallsalze von 2-N, N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxy-thiophens{ure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
DE60100625D1 (de) | Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina | |
TR200200716T2 (tr) | Ketiyapin granülleri | |
DE602004029465D1 (de) | Externes Präparat zur Behandlung von Fusspilz | |
DE60042972D1 (de) | Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung | |
DE69615400D1 (de) | 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen | |
DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
DE68917937T2 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
MY137570A (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease | |
ATE458471T1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
ATE152350T1 (de) | Pharmazeutische zusammensetzungen die 5- difluormethoxy-2-(3,4-dimethoxy-2- pyridyl)methylsulfinyl>-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten | |
DE60230629D1 (de) | Verwendung von 2,5-dihydroxybenzolsulfonsäure-derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion | |
DE60113807D1 (de) | Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans | |
DE60007548D1 (de) | Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit | |
DE69903610T2 (de) | Verfahren zur Herstellung von 5,5'-bi-1H-Tetrazol-Salz | |
ATE12649T1 (de) | Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate. | |
RU92001958A (ru) | Способ получения фибринной пасты | |
DE60114532D1 (de) | Verfahren zur Herstellung von optisch activem 1H-3-Aminopyrrolidin und Derivaten davon | |
ATE218869T1 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen | |
DE69104058T2 (de) | N-[(2-thenoylmerkapto-3-methyl)-butanoyl]-homocysteinthiolacton, verfahren zu seiner herstellung und diese enthaltende pharmaceutische zusammensetzungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |